GSK plc (LON:GSK)

Market Cap	60.58B
Revenue (ttm)	31.38B
Net Income (ttm)	2.58B
Shares Out	4.08B
EPS (ttm)	0.62
PE Ratio	23.89
Forward PE	8.75
Dividend	0.61 (4.11%)
Ex-Dividend Date	Feb 20, 2025

Volume	8,803,687
Average Volume	11,409,958
Open	1,487.50
Previous Close	1,485.00
Day's Range	1,485.50 - 1,512.50
52-Week Range	1,282.50 - 1,823.50
Beta	0.29
RSI	50.04
Earnings Date	Apr 28, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medi...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1715
• Employees: 68,629
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GSK

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.